Claritev (NYSE: CTEV) net income
Claritev reported a net loss of $284.3m for fiscal 2025; in fiscal 2024 it reported a net loss of $1,646m. Earnings per share were −$17.30.
Claritev's best year of the last 7 was fiscal 2021. It reported a loss in 5 of those 7 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$284.3m | — | −29.4% | −$17.30 |
| 2024 | −$1,646m | — | −176.9% | −$101.92 |
| 2023 | −$91.7m | — | −9.5% | −$0.14 |
| 2022 | −$572.9m | −661.2% | −53.1% | −$0.90 |
| 2021 | $102.1m | — | 9.1% | $0.16 |
| 2020 | −$520.6m | −5,461.1% | −55.5% | −$1.11 |
| 2019 | $9.7m | — | 1.0% | $0.02 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Claritev net income compared with its sector
By net income for its latest fiscal year, Claritev ranks 443rd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Claritev, −29.4%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 441st | Relay Therapeutics | −$276.5m | −1,800.6% |
| 442nd | Kura Oncology | −$278.7m | −412.9% |
| 443rd | Claritev | −$284.3m | −29.4% |
| 444th | Syndax Pharmaceuticals | −$285.4m | −165.6% |
| 445th | Madrigal Pharmaceuticals | −$288.3m | −30.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Claritev
- How much did Claritev earn in fiscal 2025?
- Claritev reported a net loss of $284.3m for fiscal 2025. In fiscal 2024 it reported a net loss of $1,646m.
- What are the earnings per share of Claritev?
- They were −$17.30 in fiscal 2025, compared with −$101.92 in fiscal 2024.
- What was the most profitable year for Claritev?
- Of its last 7 fiscal years, fiscal 2021, with $102.1m.
- Where does Claritev rank in its sector by net income?
- It ranks 443rd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Claritev come from?
- From the annual report (Form 10-K) that Claritev files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Claritev files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Claritev: the Claritev page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.